المؤلفون: Thayana A. Cruz, Nicholas R. Larson, Yangjie Wei, Natalia Subelzu, Yaqi Wu, Christian Schöneich, Leda R. Castilho, Charles Russell Middaugh

المصدر: Biologics, Vol 4, Iss 3, Pp 294-313 (2024)

مصطلحات موضوعية: anti-PCSK9 monoclonal antibody, evolocumab, Repatha, mAb characterization, critical quality attributes (CQAs), Biology (General), QH301-705.5

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2673-8449/4/3/19; https://doaj.org/toc/2673-8449

URL الوصول: https://doaj.org/article/4ce9af17cf744b2d9eec9bbc902b6693

المؤلفون: Eva Gorn

مصطلحات موضوعية: red meat and cholesterol, red meat cholesterol, red wine and cholesterol, red wine cholesterol, repatha cholesterol, salmon cholesterol, salt and cholesterol, salt cholesterol, scallops cholesterol, smoking and cholesterol, smoking cholesterol

Relation: https://doi.org/10.5281/zenodo.7070375; https://doi.org/10.5281/zenodo.7070376; oai:zenodo.org:7070376

الاتاحة: https://doi.org/10.5281/zenodo.7070376

المؤلفون: Jonguk Kim, Uichan Hong, Cindy W. Yoon, Jin Woo Bae, Joung-Ho Rha, Hee-Kwon Park

مصطلحات موضوعية: Neurology and Neuromuscular Diseases, Neurogenetics, mechanical thrombectomy, ischemic stroke, PCSK9 inhibitors, lipid lower medications, functional outcome after acute stroke, hemorrhagic transformation, evolocumab (Repatha)

Relation: https://figshare.com/articles/dataset/Data_Sheet_1_PCSK9_inhibitor_in_acute_ischemic_stroke_patient_receiving_mechanical_thrombectomy_early_outcomes_and_safety_docx/25834510

الاتاحة: https://doi.org/10.3389/fneur.2024.1375609.s001
https://figshare.com/articles/dataset/Data_Sheet_1_PCSK9_inhibitor_in_acute_ischemic_stroke_patient_receiving_mechanical_thrombectomy_early_outcomes_and_safety_docx/25834510

المؤلفون: Jetty V, Glueck CJ, Lee K, Goldenberg N, Prince M, Kumar A, Goldenberg M, Anand I, Wang P

المصدر: Vascular Health and Risk Management, Vol Volume 13, Pp 247-253 (2017)

مصطلحات موضوعية: PCSK9 inhibitors, Praluent (alirocumab [ALI]), Repatha (evolocumab[EVO]), LDL cholesterol (LDLC), heterozygous familial hypercholesterolemia (HeFH), atherosclerotic cardiovascular disease (CVD), Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

Relation: https://www.dovepress.com/eligibility-for-alirocumab-or-evolocumab-treatment-in-1090-hypercholes-peer-reviewed-article-VHRM; https://doaj.org/toc/1178-2048

URL الوصول: https://doaj.org/article/5943878e789c475d8bc7530d332056cf

المؤلفون: Kandasamy, Arulmozhi D.

المصدر: Diabesity; Vol. 3 No. 2 (2017); 5-8 ; 2369-0569

مصطلحات موضوعية: PCSK9 inhibitors, Praluent, alirocumab, Repatha, evolocumab, LDL, HDL, cholesterol

وصف الملف: application/pdf; image/jpeg

Relation: https://diabesity.ejournals.ca/index.php/diabesity/article/view/39/84; https://diabesity.ejournals.ca/index.php/diabesity/article/view/39/85; https://diabesity.ejournals.ca/index.php/diabesity/article/view/39

الاتاحة: https://diabesity.ejournals.ca/index.php/diabesity/article/view/39
https://doi.org/10.15562/diabesity.2017.39

المؤلفون: Fahey, Kelly Marie

Thesis Advisors: Symes, Karen

مصطلحات موضوعية: Health sciences, ASCVD, Evolocumab, Repatha, Familial hypercholesterolemia

الاتاحة: https://hdl.handle.net/2144/33009

المؤلفون: Sert, Ceren

مصطلحات موضوعية: Lipidstoffwechsel, Atherosklerose, kardiovaskuläres Event, PCSK9, PCSK9-Inhibitor, Alirocumab, Evolocumab, Repatha, Praluent, LDL-Cholesterin, Lp(a), arterielle Verschlusskrankheit, KHK, cAVK, pAVK, familiäre Hypercholesterinämie, lipid metabolism, atherosclerosis, cardiovascular event, PCSK9 inhibitor, LDL cholesterol, cardiovascular disease, coronary artery disease, cerebrovascular disease, peripheral artery disease, familial hypercholesterolemia

جغرافية الموضوع: UMW:14572

وصف الملف: 78 Seiten; text/html

Relation: vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:1-48404/128; urn:nbn:at:at-ubmuw:1-48404; https://resolver.obvsg.at/urn:nbn:at:at-ubmuw:1-48404; local:99147119954303331; system:AC16723409

الاتاحة: https://resolver.obvsg.at/urn:nbn:at:at-ubmuw:1-48404

المؤلفون: Aparicio Hernández, R., García Luque, A., Pérez Morán, M.J., Sánchez López, P.

المصدر: Sanidad Militar, Volume: 71, Issue: 3, Pages: 186-195, Published: SEP 2015

مصطلحات موضوعية: Lixiana®, Keytruda®, Hetlioz®, Opdivo®, 177LU, Netupitant/ palonosetron, Tasimelteon, Lumark®, Synjardy®, Vacuna frente al virus del papiloma humano nonavalente, Atazanavir / Cobicistat, Nivolumab BMS®, Lenvatinib, Cloruro de lutecio, Omidria®, Dinutuxima, Fenilefrina / ketorolaco, Akynzeo®, Evolocumab, Unituxin®, Nivolumab, Gardasil 9®, Evotaz®, Empagliflozina/metformina, Edoxaban, Repatha®, Pembrolizumab, Lenvima®

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______624::d6c13ad8bc6a2242cdcc42d7193ca7ee
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1887-85712015000300006&lng=en&tlng=en

المؤلفون: Aparicio Hernández,R., García Luque,A., Pérez Morán,M.J., Sánchez López,P.

المصدر: Sanidad Militar v.71 n.3 2015

مصطلحات موضوعية: Atazanavir / Cobicistat, Evotaz®, Cloruro de lutecio, 177LU, Lumark®, Dinutuxima, Unituxin®, Edoxaban, Lixiana®, Empagliflozina/metformina, Synjardy®, Evolocumab, Repatha®, Fenilefrina / ketorolaco, Omidria®, Lenvatinib, Lenvima®, Netupitant/ palonosetron, Akynzeo®, Nivolumab, Opdivo®, Nivolumab BMS®, Pembrolizumab, Keytruda®, Tasimelteon, Hetlioz®, Vacuna frente al virus del papiloma humano nonavalente, Gardasil 9®

وصف الملف: text/html

الاتاحة: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1887-85712015000300006

المؤلفون: R. Aparicio Hernández, P. Sánchez López, M.J. Pérez Morán, A. García Luque

المصدر: Sanidad Militar v.71 n.3 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname

مصطلحات موضوعية: Lixiana®, Keytruda®, Hetlioz®, Opdivo®, 177LU, Netupitant/ palonosetron, Tasimelteon, Lumark®, Synjardy®, Vacuna frente al virus del papiloma humano nonavalente, Atazanavir / Cobicistat, Nivolumab BMS®, Lenvatinib, Cloruro de lutecio, Omidria®, General Environmental Science, Dinutuxima, General Engineering, Authorization, Fenilefrina / ketorolaco, Akynzeo®, Evolocumab, Unituxin®, Nivolumab, Gardasil 9®, Product (mathematics), General Earth and Planetary Sciences, Evotaz®, Business, Empagliflozina/metformina, Edoxaban, Repatha®, Humanities, Pembrolizumab, Lenvima®

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb8f4393d7196b7f89bced30846126e1
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1887-85712015000300006

المؤلفون: A. Ramirez, P. P. Hu

المصدر: Clinical Medicine Insights: Cardiology, Vol 9 (2015)
Clinical Medicine Insights: Cardiology, Vol 2015, Iss 9, Pp 113-117 (2015)
Clinical Medicine Insights. Cardiology

مصطلحات موضوعية: lcsh:Diseases of the circulatory (Cardiovascular) system, OSLER, TRIUMPH, PAF-AH, LIPG, alirocumab, niacin, PCSK9, chemistry.chemical_compound, High-density lipoprotein, Hyperlipidemia, AIM-HIGH, hyperlipidemia, Myocardial infarction, ApoA-I, repatha, proprotein, myocardial infarction, high density lipoprotein, acetylhydrolase, HDL subclass, Cardiology, lipids (amino acids, peptides, and proteins), ODYSSEY, Cardiology and Cardiovascular Medicine, medicine.medical_specialty, HDL, review, apolipoprotein, HP2-THRIVE, Biosynthesis, LDL, storage, elimination, Internal medicine, CETP, medicine, HDL-C, Risk factor, kexin, PON1, paraoxonase-1, Alirocumab, heart attack, low HDL, PCSK, ApoA-II, business.industry, Cholesterol, praluent, dyslipidemia, statin, cholesterol, endothelial lipase gene, nutritional and metabolic diseases, sublisin, medicine.disease, convertase, Short Review, Evolocumab, chemistry, Apo, evolocumab, monoclonal antibody, atheroprotective, lcsh:RC666-701, platelet activating factor, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212c57e0090627db88185443c097f3eb
https://doaj.org/article/4b3c11b2597e42d3b96196f00f10ebee

المؤلفون: Pasteiner, Martina

مصطلحات موضوعية: PCSK9-Inhibitor, Alirocumab, Evolocumab, familiäre Hypercholesterinämie, Lp(a), LDL-Cholesterin, Atherosklerose, PCSK9-i-Erstverordnungszentrum, Sekundärprävention, Primärprävention, Hypercholesterinämie, DLCN, Simon Broome, MEDPED, Statine, Ezetimibe, Erstattungskodex, Therapieeffizienz, arterielle Verschlusskrankheit, cAVK, KHK, pAVK, AKH, Praluent, Repatha, familial hypercholesterolaemia, LDL-cholesterol, atherosclerosis, PCSK9-i, secondary prevention

جغرافية الموضوع: Wien, WB 425, UMW:14572

وصف الملف: 89 Seiten; text/html; Illustrationen

Relation: vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:1-24283/128; urn:nbn:at:at-ubmuw:1-24283; https://resolver.obvsg.at/urn:nbn:at:at-ubmuw:1-24283; local:99145322765803331; system:AC15619270

الاتاحة: https://resolver.obvsg.at/urn:nbn:at:at-ubmuw:1-24283